Table 4.
Adverse events
| Adverse events | Grades | ||||
|---|---|---|---|---|---|
|
1 (n, %) |
2 (n, %) |
3 (n, %) |
4 (n, %) |
Total (n, %) |
|
| Hand-foot syndrome | 5 (12.2%) | 9 (22.0%) | 5 (12.2%) | 0 (0%) | 19 (46.4%) |
| Mucositis | 3 (7.3%) | 6 (14.6%) | 8 (19.5%) | 0 (0%) | 17 (41.5%) |
| Anorexia | 12 (29.3%) | 3 (7.3%) | 1 (2.4%) | 0 (0%) | 16 (39.0%) |
| Fatigue | 4 (9.8%) | 7 (17.1%) | 5 (12.2%) | 0 (0%) | 16 (39.0%) |
| Proteinuria | 11 (26.8%) | 4 (9.8%) | 0 (0%) | 0 (0%) | 15 (36.6%) |
| Hypertension | 5 (12.2%) | 6 (14.6%) | 3 (7.3%) | 0 (0%) | 14 (34.1%) |
| Pain | 6 (14.6%) | 4 (9.8%) | 1 (2.4%) | 0 (0%) | 11 (26.8%) |
| Thrombocytopenia | 6 (14.6%) | 3 (7.3%) | 2 (4.9%) | 0 (0%) | 11 (26.8%) |
| Neutropenia | 2 (4.9%) | 2 (4.9%) | 1 (2.4%) | 0 (0%) | 5 (12.2%) |
| Transaminase increased | 1 (2.4%) | 3 (7.3%) | 1 (2.4%) | 0 (0%) | 5 (12.2%) |
| Diarrhea | 1 (2.4%) | 2 (4.9%) | 0 (0%) | 0 (0%) | 3 (7.3%) |